EDGAR Filing Documents for 0001647488-15-000127

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001647488-15-000127

Filing Date

2015-10-07

Accepted

2015-10-07 16:19:21

Documents

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	MAINBODY	mainbody.htm	POS AM	1450474
2	EXHIBIT 23.1	ex23_1.htm	EX-23.1	3449
3	EXHIBIT 23.3	ex23_3.htm	EX-23.3	1233
4	GRAPHIC	image_001.jpg	GRAPHIC	3991
5	GRAPHIC	image_002.jpg	GRAPHIC	6290
	Complete submission text file	0001647488-15-000127.txt		6787130

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	rcha-20150331.xml	EX-101.INS	1369938
7	XBRL SCHEMA FILE	rcha-20150331.xsd	EX-101.SCH	59834
8	XBRL CALCULATION FILE	rcha-20150331_cal.xml	EX-101.CAL	38053
9	XBRL DEFINITION FILE	rcha-20150331_def.xml	EX-101.DEF	254016
10	XBRL LABEL FILE	rcha-20150331_lab.xml	EX-101.LAB	271184
11	XBRL PRESENTATION FILE	rcha-20150331_pre.xml	EX-101.PRE	346019

Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212

Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001

Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: POS AM | Act: 33 | File No.: 333-204358 | Film No.: 151149108
SIC: 2834 Pharmaceutical Preparations